Dihydrexidine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDihydrexidine
Drug Alias NameIP-202DAR-100DAR-0100DAR-100A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsSchizophreniaSchizotypal Personality DisorderCognition Disorders +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue PharmaUnc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSchizophreniaSchizotypal Personality DisorderCognition Disorders +[5

Other Information

ATC CodeN/A
Related LinksWikipedia